ZBIOInvestor Events•globenewswire•August 26, 2025 at 11:05 AM

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Sentiment:Negative (20)

Summary

WALTHAM, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for autoimmune diseases, today announced management’s presentations at the following investor conferences in September:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 26, 2025 by globenewswire